Liver transplantation

Journal of Hepatology

Volumn 32, Issue SUPPL.1, 2000, Pages 198-207

  Neuberger, James ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Donor shortage; Immunosuppression; Liver transplantation; Tolerance

Indexed keywords

15 DEOXYSPERGUALIN; AZATHIOPRINE; BREQUINAR; CORTICOSTEROID; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; LEFLUNOMIDE; MIZORIBINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS; TERIFLUNOMIDE;

CELL TRANSPLANTATION; DRUG INDUCED DISEASE; GRAFT REJECTION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; LIVER CELL; LIVER TRANSPLANTATION; LIVING DONOR; MALIGNANT NEOPLASTIC DISEASE; ORGAN DONOR; PRIORITY JOURNAL; QUALITY OF LIFE; RECURRENT DISEASE; REPERFUSION INJURY; REVIEW; SURVIVAL; TREATMENT OUTCOME; VASCULAR DISEASE; XENOTRANSPLANTATION;

CELL TRANSPLANTATION; HUMANS; IMMUNE TOLERANCE; LIVER; LIVER TRANSPLANTATION; TISSUE AND ORGAN PROCUREMENT; TRANSPLANTATION, HETEROLOGOUS; WAITING LISTS;

EID: 0034048670     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0168-8278(00)80426-2     Document Type: Article

References (66)

1. Gilbert JR, Pascual M, Schoenfeld DA, Rubin RH, Delmonico FL, Cosimi AB. Evolving trends in liver transplantation. Transplantation 1999; 67: 246-53.
2. Gralnek IM, Liu H, Shapiro MF, Martin P. United States Liver Donor population in the 1990s. Transplantation 1999; 67: 1019-23.
3. Lucey MR, Brown KA, Everson GT, Fung JJ, Gish R, Keefe EB, et al. Minimal criteria for placement of adults on the liver transplant waiting list. Transplantation 1998; 66: 956-62.
4. Neuberger J, James OF. Allocation of scarce donor livers. Lancet 1999; 354: 1636-9.
5. Neuberger J, Adams DH, MacMaster P, Maidment A, Speed M. Assessing priorities for allocation of donor grafts: survey of public and clinicians. Br Med J 1998; 317: 172-5.
6. Ubel PA, Lowenstein G. Distributing scarce livers: the moral reasoning of the general public. Soc Sci 1996; 42: 1049-55.
7. O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97: 439-45.
8. Neuberger J. Prognostic models - what is their future? Eur J Gastroenterol Hepatol 1997; 9: 1145-7.
9. Christensen E, Gunson BK, Neuberger J. Optimal timing of liver transplantation for patients with primary biliary cirrhosis: use of prognostic modelling. J Hepatol 1999; 30: 285-92.
10. Clavien PA, Selzner M, Tuttle-Newhall JE, Harland RC, Suhocki P. Liver transplantation complicated by misplaced TIPS in the portal vein. Ann Surg 1998; 227: 440-5.
11. Mirza D, Gunson B, Da Silva R, Mayer AD, Buckels JAC, McMaster P. Policies in Europe on "marginal quality donor livers". Lancet 1994; 344: 1480.
12. Washburn WK, Johnson LB, Lewis WD, Jenkins RL. Graft function and outcome of older (≥60 years) donor livers. Transplantation 1996; 61: 1062-5.
13. Sindhi R, Rosendale J, Mundy D, Taranto S, Baliga P, Reuben A, et al. Impact of segmental grafts on pediatric liver transplantation - a review of the United Network for Organ Sharing Scientific Registry data (1990-1996). J Pediatr Surg 1999; 34: 107-10.
14. Dyer PA, Bobrow M. Domino hepatic transplantation using the liver from a patient with familial amyloid polyneuropathy. Transplantation 1999; 67: 1202.
15. Reding R, de Goyet J de V, Delbeke I, Sokal E, Jamart J, Janssen M, et al. Pediatric liver transplantation with cadaveric or living related donors: comparative results in 90 elective recipients of primary grafts. J Pediatr 1999; 134: 280-6.
16. Wachs ME, Bak TE, Karrer FM, Everson GT, Shrestha R, Trouillot TE, et al. Adult living donor liver transplantation using a right hepatic lobe. Transplantation 1998; 68: 1313-6.
17. Grewel HP, Thistlewaite JR, Loss GE, Fisher JS, Cronin DC, Siegel CT, et al. Complications in 100 living donors. Ann Surg 1998; 228: 214-9
18. Chowdhury JR. Prospects of liver cell transplantation and liverdirected gene therapy. Semin Liver Dis 1999; 19: 1-6.
19. Grompe M, Laconi E, Shafritz DA. Principles of therapeutic repopulation. Semin Liver Dis 1999; 19: 7-14.
20. Petersen BE, Bowen WC, Patrene KD, Mars WM, Sullivan AK, Murase N, et al. Bone marrow as a potential source of hepatic oval cells. Science 1999; 284: 1168-70.
21. Lambrigts D, Sachs DH, Cooper DK. Discordant organ xenotransplantation in primates: world experience and current status. Transplantation 1998; 66: 547-61.
22. Harland RC, Platt JL. Prospects for xenotransplantation of the liver. J Hepatol 1996; 25: 248-58.
23. Fung JJ, Rao A, Starzl TE. Clinical trials and projected future of liver xenotransplantation. World J Surg 1997; 21: 956-61.
24. Bradley AJ. Overcoming the immunological barriers to xenotransplantation. Transplantation 1999: (in press).
25. Cozzi E, Tucker AW, Langford GA, Pino-Chavez G, Wright L, O'Connell MJ, Young VJ, et al. Characterization of pigs transgenic for human decay accelerating factor. Transplantation 1997; 64: 1383-92.
26. Starzl TE, Rao AS, Murase N, Fung JJ, Demetris AJ. Will xenotransplantation ever be feasible? J Am Coll Surg 1998; 186: 383-7.
27. Levy MF, Crippen JS, Sutton SW, Netto G, Jung GJ, Molmenti EP, et al. Two patients undergo liver allotransplantation (OLTX) following extracorporeal hepatic support with transgenic (hCD55/hCD59) porcine livers: clinical results and lack of pig to human transmission of the porcine endogenous retrovirus (PoERV). Transplantation 1999; 67: S596.
28. Abbasoglu O, Levy SF, Brkic BB, Testa G, Jeyarajah DR, Goldstein RM, et al. Ten years of transplantation: an evolving understanding of late graft loss. Transplantation 1997; 64: 1801-7.
29. Asfar S, Metrakos P, Fryer J, Verran D, Ghent C, Grant D, et al. An analysis of late deaths after liver transplantation. Transplantation 1996; 61: 1377-81.
30. Ryckman FC, Alonso MH, Bucuvalas JC, Balistreri WF. Long-term survival after liver transplantation. J Pediatr Surg 1999; 34: 845-9.
31. Sudan DL, Venkataramani A, Lynch J, Fox IJ, Shaw B, Langnas AN. Causes of late mortality in survivors of liver transplantation. Transplantation 1999: 67: S564 (abstract).
32. Molmenti EP, Levy MF, Jung G, Jennings LW, Crippen JS, Conkey AC, et al. Outcome 10 years after transplantation. Transplantation 1999; 67: S563 (abstract).
33. Goff JS, Glazner J, Bilir BM. Measuring outcome after liver transplantation: a critical review. Liver Transplant Surg 1998; 4: 189-96.
34. Bryan S, Ratcliffe J, Neuberger JM, Burroughs AK, Gunson BK, Buxton MJ. Health-related quality of life following liver transplantation. Qual Life Res 1998; 7: 115-20.
35. Bonsel GJ, Essink-Bot ML, Klompmaker JJ, Sloof MJH. Assessment of the quality of life before and following liver transplantation. Transplantation 1992; 53: 796-800.
36. Price CE, Lowe D, Cohen AT, Reid FT, Forbes GM, McEwen J, et al. Prospective study of the quality of life in patients assessed for liver transplantation. J Roy Soc Med 1995; 88: 130-5.
37. Belle SH, Porayko MK, Hoofnagle JH, Lake JR, Zetterman RK for the NIDDK Transplantation Database. Changes in quality of life after liver transplantation among adults. Liver Transplant Surg 1997; 3: 93-104.
38. Hunt CM, Camargo CA, Dominitz JA, Bute BP, Clavien PM. Effect of postoperative complications on health and employment following liver transplantation. Clin Transplant 1998; 12: 99-103.
39. Gross CR, Malinchoc M, Kim WR, Evans RW, Wiesner RH, Petz JL, et al. Quality of life before and after liver transplantation for cholestatic liver disease. Hepatology 1999; 29: 235-64.
40. Singh N, Gayowski T, Wagener MM, Marino IR. Quality of life, functional status, and depression in male liver transplant recipients with recurrent viral hepatitis C. Transplantation 1999; 67: 69-72.
41. Fisher NC, Nightingale PC, Gunson BK, Lipkin G, Neuberger JM. Chronic renal failure following liver transplantation. Transplantation 1998; 66: 59-66.
42. Bennet WM, DeMattos A, Mayer MM, Andoh T, Barry JM. Chronic cyclosporin nephropathy: the Achilles heel of immunosuppressive therapy. Kidney Int 1996; 50: 1089-100.
43. Canzanello VJ, Schwartz L, Taler SJ, Textor SC, Wiesner RH, Porayko MK, et al. Evolution of cardiovascular risk after liver transplantation: a comparison of cyclosporine A and tacrolimus (FK506). Liver Transplant Surg 1997; 3: 1-9.
44. Padbury RTA, Toogood GJ, McMaster P. Withdrawal of immunosuppression in liver allograft recipients. Liver Transplant Surg 1998; 4: 242-8.
45. Candinas D, Gunson BK, Nightingale P, Hubscher SG, McMaster P, Neuberger JM. Sex mismatch as a risk factor for chronic rejection of liver allografts. Lancet 1995; 346: 1117-21.
46. van Hoek B, Wiesner RH, Krom RA, Ludwig J, Moore SB. Severe ductopenic rejection following liver transplantation: incidence, time of onset, risk factors, treatment and outcome. Semin Liver Dis 1992; 12: 41-50.
47. Watson CJ, Friend PJ, Jamieson NV, Frick TW, Alexander G, Gimson AE, et al. Sirolimus: a potent new immunosuppressant for liver transplantation. Transplantation 1999; 67: 505-9.
48. Groth CG, Backman L, Morales JM, Calne RY, Kreis H, Lang P, et al. Sirolimus (rapamycin)-based therapy in human liver transplantation. Transplantation 1999; 67: 1036-42.
49. Hebert MF, Ascher NL, Lake JR, Emond J, Nikolai B, Linna TJ, et al. Four year follow-up of mycophenolate mofetil for graft rescue in liver allograft recipients. Transplantation 1999; 67: 707-12.
50. Groth CG, Ohlamn S, Ericzon BH, Barholt L, Reinholt FP. Deoxyspergualin for liver transplant rejection. Lancet 1990; 336: 326.
51. Katoh H, Phkohchi N, Orii T, Doi H, Satomi S. Effectiveness of 15-deoxyspergualin on steroid resistant acute rejection in living related liver transplantation. Transplant Proc 1997; 29: 553-4.
52. Ostraat O, Qi ZQ, Tufveson G, Hedlund G, Ekberg H. The effects of leflunomide and cyclosporin A on rejection of cardiac allografts in the rat. Scand J Immunol 1998; 47: 236-42.
53. Calne RY, Friend P, Moffat S, Bradley A, Hale G, Firth J, et al. Prope tolerance, perioperative Campath 1H and low dose cyclosporin monotherapy in renal allograft recipients. Lancet 1998; 351: 1701-2.
54. Neuberger J, Adams DH. What is the significance of acute liver allograft rejection? J Hepatol 1998; 29: 143-50.
55. Opelz G. Collaborative Transplant Study. 10 year report. Transplant Proc 1992; 24: 2342-55.
56. Hathaway M, Gunson BK, Keogh AC, Briggs DC, McMaster P, Neuberger J. A positive cross-match in liver transplantation - no effect or inappropriate analysis? A prospective study. Transplantation 1997; 64: 54-9.
57. Kamada N, Wight DD. Antigen-specific immunosuppression induced by liver transplantation in the rat. Transplantation 1984; 38: 217-21.
58. Mazariegos GV, Reyes J, Marino IR, Demetris AJ, Flynn B, Irish W, et al. Weaning of immunosuppression in liver transplant recipients. Transplantation 1997; 63: 243-9.
59. Devlin J, Doherty D, Thomson L, Wong T, Donaldson P, Portmann B, et al. Defining the outcome of immunosuppression withdrawal after liver transplantation. Hepatology 1998; 27: 926-33.
60. Hollander GA, Zuklys S, Forster E, Krenger W. On costimulatory signals and T cell tolerance: relevance for transplantation immunity. Transplant Proc 1999; 31(suppl1/2A): 25S-32S.
61. Mutimer D, Pillay D, Dragon E, Tang H, Ahmed M, O'Donnell K, et al. High pre-treatment serum hepatitis B virus titre predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantation. J Hepatol 1999; 30: 715-21.
62. Gane EJ, Portmann BC, Naoumov N, Smith HM, Underhill JA, Donaldson PT, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996; 334: 815-20.
63. Papatheoridis GV, Patch D, Dusheiko GM, Burroughs AK. The outcome of hepatitis C virus infection after liver transplantation - is it influenced by the type of immunosuppression? J Hepatol 1999; 30: 731-8.
64. Van Hoek B, de Boer J, Boudjema K, Williams R, Corsmit O, Terpstra OT on behalf of the EURALT Study Group. Auxiliary versus orthotopic liver transplantation for acute liver failure. J Hepatol 1999; 30: 699-705.
65. Inomata Y, Kiuchi T, Kim I, Uemoto S, Egawa H, Asonuma K, et al. Auxiliary partial orthotopic living donor liver transplantation as an aid for small-for-size grafts in larger recipients. Transplantation 1999; 67: 1314-9.
66. Rela M, Muiesan P, Vilca-Melendez H, Dhawan A, Baker A, Mieli Vergani G, Heaton ND. Auxiliary partial orthotopic liver transplantation for Crigler-Najjar syndrome type I. Ann Surg 1999; 229: 565-9.